Form 4 for PBYI PUMA BIOTECHNOLOGY, INC.
Accepted 2022-06-16 00:00:00 ET · period of report 2022-06-14 · accession 0001437749-22-015215 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-06-16 | 2022-06-14 | PBYI | Stuglik Brian M | Dir | A - Grant | $0.00 | +27.0K | 54.9K | +97% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-14 | A | A | 27,000 | $0.00 | 54,858 | D | — | — | (F1) Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer. |